GLUCOMINERALORET

THE GLUCO- AND MINERALO-CORTICOID PATHWAYS IN RETINA: MOLECULAR CARACTERISATION AND THERAPEUTIC IMPLICATION

 Coordinatore INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 

 Organization address address: 101 Rue de Tolbiac
city: PARIS
postcode: 75654

contact info
Titolo: Ms.
Nome: Mihaja
Cognome: Auguste
Email: send email
Telefono: 33148073415
Fax: 33148073432

 Nazionalità Coordinatore France [FR]
 Totale costo 45˙000 €
 EC contributo 45˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2010-RG
 Funding Scheme MC-ERG
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-05-01   -   2014-12-24

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

 Organization address address: 101 Rue de Tolbiac
city: PARIS
postcode: 75654

contact info
Titolo: Ms.
Nome: Mihaja
Cognome: Auguste
Email: send email
Telefono: 33148073415
Fax: 33148073432

FR (PARIS) coordinator 45˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

patients    specificity    diabetic    dme    edema   

 Obiettivo del progetto (Objective)

'Considering the alarming rate of diabetic patients becoming blind after retinal edema formation, and the important risks of ocular complications due to the low specificity of the current glucocorticoid (GC) treatment, it is imperative to bring together all the necessary means for the development of novel therapies with better specificity, efficiency and limited secondary effects. To that end, it is crucial to fill the gap in the fundamental knowledge of diabetic macular edema (DME) physiopathology. By taking advantage of an existing beneficial but imperfect anti-edematous therapy (low specificity), we propose to use state-of-the-art methods to perform a wide and unique study on the mechanisms i) involved in diabetic retinopathy ii) and regulated by the corticosteroids, with the aim to potentiate the therapeutic effect of GCs, for a real restoration of vision in DME patients.'

Altri progetti dello stesso programma (FP7-PEOPLE)

EYELEVEL (2010)

Levels of cognitive organization in human eye movements

Read More  

FLUIDGRAVITY (2011)

Fluid Dynamics and Quantum Gravity

Read More  

CARDIF (2011)

Physiological impact of IF1 inhibitor on Reverse Cholesterol Transport (RCT) and atherosclerosis

Read More